A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity-Reference-Cited by-同舟云学术

A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity

Published:2016-05 Issue: Volume:17 Page:e93-e104
ISSN:1558-2027
Container-title:Journal of Cardiovascular Medicine
language:en
Short-container-title:Journal of Cardiovascular Medicine

Author:

Maurea Nicola,Spallarossa Paolo,Cadeddu Christian,Madonna Rosalinda,Mele Donato,Monte Ines,Novo Giuseppina,Pagliaro Pasquale,Pepe Alessia,Tocchetti Carlo G.,Zito Concetta,Mercuro Giuseppe

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference72 articles.

1. Prevention of Anthracycline-Induced Cardiotoxicity

2. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data

3. Chemotherapy-Induced Cardiotoxicity: Detection, Prevention, and Management

4. Angiogenesis as a therapeutic target

5. Understanding, recognizing, and managing toxicities of targeted anticancer therapies

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into cardiovascular toxicity of cancer targeted and immune therapies: Beyond ischemia with non-obstructive coronary arteries (INOCA);American Heart Journal Plus: Cardiology Research and Practice;2024-04

2. Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies;Current Heart Failure Reports;2023-01-25

3. CDK4/6 inhibitors: basics, pros, and major cons in breast cancer treatment with specific regard to cardiotoxicity – a narrative review;Therapeutic Advances in Medical Oncology;2023-01

4. Does the HFA/ICOS tool overestimate the risk of cardiovascular toxicities in oncologic patients scheduled to receive anti-VEGF agents?;Journal of Cardiovascular Medicine;2022-12

5. Diversity of Cardiologic Issues in a Contemporary Cohort of Women With Breast Cancer;Frontiers in Cardiovascular Medicine;2021-10-01